Artelo Biosciences, Inc.
ARTL
$1.04
$0.010.97%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -2.81% | -19.99% | -21.36% | -23.09% | -29.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.79% | -6.20% | 10.14% | -3.82% | -3.47% |
| Operating Income | -1.79% | 6.20% | -10.14% | 3.82% | 3.47% |
| Income Before Tax | -5.78% | 4.54% | -10.62% | 6.63% | 7.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.78% | 4.54% | -10.62% | 6.63% | 7.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.78% | 4.54% | -10.62% | 6.63% | 7.87% |
| EBIT | -1.79% | 6.20% | -10.14% | 3.82% | 3.47% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 2.37% | 14.43% | -0.37% | 13.45% | 12.43% |
| Normalized Basic EPS | 6.08% | 15.91% | 0.08% | 10.80% | 8.23% |
| EPS Diluted | 2.29% | 14.36% | -0.44% | 13.38% | 12.41% |
| Normalized Diluted EPS | 6.08% | 15.91% | 0.08% | 10.80% | 8.23% |
| Average Basic Shares Outstanding | 9.00% | 11.64% | 10.17% | 7.15% | 4.48% |
| Average Diluted Shares Outstanding | 9.00% | 11.64% | 10.17% | 7.15% | 4.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |